5-88882866-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002397.5(MEF2C):​c.-143+89A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 151,962 control chromosomes in the GnomAD database, including 2,812 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.19 ( 2812 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

MEF2C
NM_002397.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.470

Publications

9 publications found
Variant links:
Genes affected
MEF2C (HGNC:6996): (myocyte enhancer factor 2C) This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe cognitive disability, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
MEF2C Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 5-88882866-T-C is Benign according to our data. Variant chr5-88882866-T-C is described in ClinVar as Benign. ClinVar VariationId is 1229073.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.269 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002397.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEF2C
NM_002397.5
MANE Select
c.-143+89A>G
intron
N/ANP_002388.2
MEF2C
NM_001193347.1
c.-143+4636A>G
intron
N/ANP_001180276.1
MEF2C
NM_001193350.2
c.-140+89A>G
intron
N/ANP_001180279.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEF2C
ENST00000504921.7
TSL:1 MANE Select
c.-143+89A>G
intron
N/AENSP00000421925.5
MEF2C
ENST00000340208.9
TSL:1
c.-143+4636A>G
intron
N/AENSP00000340874.5
MEF2C
ENST00000437473.6
TSL:1
c.-140+89A>G
intron
N/AENSP00000396219.2

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28308
AN:
151842
Hom.:
2806
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.276
Gnomad ASJ
AF:
0.222
Gnomad EAS
AF:
0.0974
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.152
Gnomad MID
AF:
0.290
Gnomad NFE
AF:
0.164
Gnomad OTH
AF:
0.212
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
8
Hom.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.187
AC:
28345
AN:
151962
Hom.:
2812
Cov.:
31
AF XY:
0.187
AC XY:
13868
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.198
AC:
8210
AN:
41390
American (AMR)
AF:
0.276
AC:
4218
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.222
AC:
770
AN:
3466
East Asian (EAS)
AF:
0.0971
AC:
502
AN:
5172
South Asian (SAS)
AF:
0.239
AC:
1150
AN:
4808
European-Finnish (FIN)
AF:
0.152
AC:
1612
AN:
10588
Middle Eastern (MID)
AF:
0.291
AC:
85
AN:
292
European-Non Finnish (NFE)
AF:
0.164
AC:
11154
AN:
67950
Other (OTH)
AF:
0.216
AC:
455
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1143
2286
3430
4573
5716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
314
628
942
1256
1570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.183
Hom.:
2098
Bravo
AF:
0.200
Asia WGS
AF:
0.197
AC:
686
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.8
DANN
Benign
0.65
PhyloP100
-0.47
PromoterAI
0.0014
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10044342; hg19: chr5-88178683; API